Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-26

Clinical Trial Update: T-Regulatory Cells in Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating T-regulatory cell therapy for Amyotrophic Lateral Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanley H. Appel, MD | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | Status: UNKNOWN